| Literature DB >> 28830509 |
Nicole L Lebo1, Lisa Caulley2, Hussain Alsaffar2, Martin J Corsten3, Stephanie Johnson-Obaseki2.
Abstract
BACKGROUND: Pharyngocutaneous fistula (PCF) is a problematic complication following total laryngectomy. Disagreement remains regarding predisposing factors. This study examines perioperative factors predicting PCF following total laryngectomy using a large multicenter data registry.Entities:
Keywords: Laryngectomy; National surgical quality improvement program; Peri-operative; Pharyngocutaneous fistula; Predisposing factors
Mesh:
Year: 2017 PMID: 28830509 PMCID: PMC5568352 DOI: 10.1186/s40463-017-0233-z
Source DB: PubMed Journal: J Otolaryngol Head Neck Surg ISSN: 1916-0208
Relevant Current Procedural Terminology (CPT) Code Definitions
| CPT Code | Definition |
|---|---|
| Primary procedure | |
| 31,360 | Laryngectomy; total, without radical neck dissection |
| 31,365 | Laryngectomy; total, with radical neck dissection |
| 31,367 | Laryngectomy; subtotal supraglottic, without radical neck dissection |
| 31,368 | Laryngectomy; subtotal supraglottic, with radical neck dissection |
| 31,370 | Partial laryngectomy (hemilaryngectomy); horizontal |
| 31,375 | Partial laryngectomy (hemilaryngectomy); laterovertical |
| 31,380 | Partial laryngectomy (hemilaryngectomy); anterovertical |
| 31,382 | Partial laryngectomy (hemilaryngectomy); antero-latero-vertical |
| 31,390 | Pharyngolaryngectomy, with radical neck dissection; without reconstruction |
| 31,395 | Pharyngolaryngectomy, with radical neck dissection; with reconstruction |
| Flap procedure | |
| 15,732 | Muscle, myocutaneous, or fasciocutaneous flap; head and neck (eg, temporalis, masseter muscle, sternocleidomastoid, levator scapulae) |
| 15,734 | Muscle, myocutaneous, or fasciocutaneous flap; trunk |
| 15,736 | Muscle, myocutaneous, or fasciocutaneous flap; upper extremity |
| 15,740 | Flap; island pedicle requiring identification and dissection of an anatomically named axial vessel |
| 15,750 | Flap; neurovascular pedicle |
| 15,756 | Free muscle or myocutaneous flap with microvascular anastomosis |
| 15,757 | Free skin flap with microvascular anastomosis |
| 15,758 | Free fascial flap with microvascular anastomosis |
| Other | |
| 31,611 | Construction of tracheoesophageal fistula and subsequent insertion of an alaryngeal speech prosthesis (eg, voice button, Blom-Singer prosthesis) |
CPT Current Procedural Terminology
Fig. 1Patient Selection Algorithm. Legend: ACS-NSQIP = American College of Surgeons - National Surgical Quality Improvement Program database; CPT = Current Procedural Terminology code
Multivariate regression analysis of risk factors for PCF in patients receiving primary closure
| Variable | Comparison | Odds Ratio | 95% CI |
|
|---|---|---|---|---|
| Age | Increase by 10 years | 0.99 | 0.68–1.43 | 0.95 |
| Gender | Male vs. female | 0.94 | 0.33–2.70 | 0.91 |
| BMI | ≥ 18.5 vs. < 18.5 kg/m2 (underweight) | 0.28 | 0.11–0.73 | 0.009 |
| Pre-op wound infection | Yes vs. no | 5.12 | 0.88–29.63 | 0.068 |
| Chronic steroid use | Yes vs. no | 3.28 | 0.89–12.13 | 0.07 |
| Wound class | Contaminated vs. Clean/Clean-contaminated | 3.01 | 0.56–16.16 | 0.20 |
| Dirty vs Clean/Clean-contaminated | 2.50 | 0.24–26.38 | 0.44 |
PCF Pharyngocutaneous fistula, CI confidence interval, BMI body mass index
Study patient demographics – overall and by reconstruction-type sub-grouping
| All patients | 1° closure | Free flap | Regional flap | |
|---|---|---|---|---|
| N | 971 | 607 | 147 | 217 |
| Gender | ||||
| Male | 776 | 483 | 110 | 183 |
| Female | 195 | 124 | 37 | 37 |
| M:F ratio | 3.98 | 3.90 | 2.97 | 4.95 |
| Age (years) | ||||
| Mean (std dev) | 62.8 (11.4) | 63.1 (12.0) | 61.6 (10.3) | 62.8 (10.7) |
| Maximum | 90 | 90 | 83 | 86 |
| Minimum | 20 | 20 | 37 | 31 |
Std dev standard deviation, M:F male to female ratio
Rate of pharyngocutaneous fistula development in all patients and by reconstruction type
| Group | Rate of PCF development |
|---|---|
| Overall (all patients) | 5.1% |
| Primary closure | 3.8% |
| Free flap | 9.5% |
| Regional flap | 5.5% |
PCF Pharyngocutaneous fistula
Multivariate regression analysis of risk factors for PCF in all patients
| Variable | Comparison | Odds Ratio | 95% CI |
|
|---|---|---|---|---|
| Age | Increase by 10 years | 1.05 | 0.78–1.42 | 0.75 |
| Gender | Male vs. female | 0.66 | 0.32–1.36 | 0.26 |
| BMI | ≥ 18.5 vs. < 18.5 kg/m2 (underweight) | 0.67 | 0.30–1.51 | 0.33 |
| Diabetes | Yes vs. no (Identified DM on oral agents or insulin in 30 days pre-op) | 1.55 | 0.64–3.73 | 0.33 |
| Smoking | Yes vs. no (current smoker within 1 year) | 1.48 | 0.76–2.89 | 0.24 |
| Functional Status | Dependent vs. independent (in last 30 days) | 0.84 | 0.27–2.63 | 0.76 |
| COPD history | Yes vs. no (history severe COPD) | 0.72 | 0.31–1.67 | 0.44 |
| CHF history | Yes vs. no (within last 30 days) | 1.33 | 0.14–12. 43 | 0.80 |
| HTN requiring medication | Yes vs. no | 0.81 | 0.41–1.57 | 0.52 |
| Pre-op wound infection | Yes vs. no (open or infected wound at site at time of OR) | 1.83 | 0.50–6.71 | 0.36 |
| Chronic steroid use | Yes vs. no | 2.39 | 0.80–7.20 | 0.12 |
| Weight loss | > 10% loss in 6mo pre-op vs. < 10% | 0.91 | 0.40–2.06 | 0.82 |
| Bleeding disorder history | Yes vs. no identified history | 1.52 | 0.31–7.54 | 0.61 |
| Pre-op transfusion | > 4 units PRBCs vs. ≤ 4 (in 72 h pre-op) | 6.28 | 1.06–37.30 | 0.04 |
| Wound class | Contaminated vs. Clean/Clean-contaminated | 6.28 | 2.29–17.94 | 0.0004 |
| Dirty vs. Clean/Clean-contaminated | 8.87 | 1.99–39.45 | 0.004 | |
| ASA Class | 3–5 vs. 1–2 | 0.93 | 0.30–2.82 | 0.89 |
| Peri-op or post-op transfusion | Yes vs. no (any transfusion of PRBC or whole blood from start of OR to 72 h post-op) | 0.80 | 0.09–6.85 | 0.84 |
| TEP insertion during procedure | Yes vs. no | 1.13 | 0.51–2.50 | 0.77 |
| Reconstruction type | Free flap vs. Primary closure | 2.81 | 1.31–5.99 | 0.008 |
| Regional flap vs. Primary closure | 1.45 | 0.67–3.11 | 0.34 | |
| Regional flap vs. Free flap | 0.51 | 0.21–1.24 | 0.14 |
PCF Pharyngocutaneous fistula, CI confidence interval, BMI body mass index, DM diabetes mellitus, COPD chronic obstructive pulmonary disease, CHF congestive heart failure, HTN hypertension, PRBCs packed red blood cells, ASA American Society of Anesthesiologists, TEP tracheoesophageal puncture